Circulating miRNA biomarkers for Alzheimer's disease.
A minimally invasive diagnostic assay for early detection of Alzheimer's disease (AD) is required to select optimal patient groups in clinical trials, monitor disease progression and response to treatment, and to better plan patient clinical care. Blood is an attractive source for biomarkers du...
Guardado en:
Autores principales: | Pavan Kumar, Zoltan Dezso, Crystal MacKenzie, Judy Oestreicher, Sergei Agoulnik, Michael Byrne, Francois Bernier, Mamoru Yanagimachi, Ken Aoshima, Yoshiya Oda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d506b339c5284f2390f8cbdf863dd996 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of cellular miRNAs on circulating miRNA biomarker signatures.
por: Radha Duttagupta, et al.
Publicado: (2011) -
Stability of Circulating Exosomal miRNAs in Healthy Subjects
por: David Sanz-Rubio, et al.
Publicado: (2018) -
Circulating microRNAs as Diagnostic Markers in Primary Aldosteronism
por: Scott M. MacKenzie, et al.
Publicado: (2021) -
Transcriptome analysis of arterial and venous circulating miRNAs during hypertension
por: Ling Jin, et al.
Publicado: (2021) -
Circulating miRNA Signatures Associated with Insulin Resistance in Adolescents with Obesity
por: Lin H, et al.
Publicado: (2020)